Rabbit model for Chlamydia pneumoniae infection.

Journal of Clinical Microbiology
I W FongJ B Mahony

Abstract

A rabbit model was established for Chlamydia pneumoniae infection that may be helpful to understand the pathogenesis of disease in humans. Twelve, pathogen-free, 1-month-old New Zealand White rabbits were inoculated with 1.0 x 10(7) to 5.0 x 10(7) CFU of purified C. pneumoniae (ATCC strain VR 1310) via the nasopharynx (1 rabbit died immediately postinoculation, and 11 were available for study). Five controls were inoculated with the carrier buffer. Ten of the 11 study rabbits demonstrated serological evidence of acute infection (immunoglobulin G antibodies, 1:8 to > 1:16), with the weakest response at 7 days and the strongest response at 28 days, whereas none of the controls showed any seroconversion. Study animals were sacrificed in batches of three, on days 7, 14, 21, and 28, but controls were sacrificed on days 7 and 28. Two-thirds of the animals demonstrated evidence of bronchiolitis and pneumonia on days 7 and 14 and resolution by day 21. Two study rabbits demonstrated, on histology, early and intermediate lesions of atherosclerosis: one animal (day 7) showed the accumulation of foamy macrophages (fatty streak) in the arch of the aorta, and the other animal (day 14) showed spindle cell proliferation of smooth muscle cells ...Continue Reading

References

May 1, 1991·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·D H ThomN S Weiss
Apr 1, 1990·The Journal of Infectious Diseases·J T GraystonS P Wang
Sep 1, 1990·The Journal of Infectious Diseases·C C Kuo, J T Grayston
Mar 1, 1990·Infection and Immunity·S M HollandT C Quinn
Apr 1, 1995·Microbial Pathogenesis·S E Kaukoranta-TolvanenK Laitinen
Aug 1, 1995·The Journal of Infectious Diseases·L A CampbellJ T Grayston
Mar 1, 1995·The Journal of Infectious Diseases·Z P YangJ T Grayston
Aug 1, 1994·The Journal of Infectious Diseases·Z P YangC C Kuo
Apr 1, 1994·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·T J Marrie
Nov 1, 1993·The Journal of Infectious Diseases·J T GraystonJ Altman
Apr 1, 1993·The Journal of Infectious Diseases·C C KuoJ T Grayston
May 1, 1993·Infection and Immunity·Z P YangJ T Grayston

❮ Previous
Next ❯

Citations

Aug 29, 1998·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M R Hammerschlag
Apr 8, 1999·Journal of Clinical Pathology·D Taylor-Robinson, B J Thomas
Jun 6, 2000·The Journal of Infectious Diseases·J B Muhlestein
Apr 3, 2001·Stroke; a Journal of Cerebral Circulation·R LaBicheT J DeGraba
Jan 17, 2002·Acta Microbiologica Et Immunologica Hungarica·Z KisE Gönczöl
Dec 18, 2002·Acta Ophthalmologica Scandinavica·Pia V VécseiGerold Stanek
Jun 10, 2005·Veterinary Research Communications·A MarangoniR Cevenini
Jul 26, 2005·Infection and Immunity·Katerina WolfTed Hackstadt
Oct 31, 2006·World Journal of Gastroenterology : WJG·Antonella MarangoniRoberto Cevenini
Mar 14, 2009·FEMS Immunology and Medical Microbiology·Jan Marco KernMatthias Maass
Mar 5, 2009·Rheumatology·Cristina C BeliznaYehuda Shoenfeld
Jul 27, 2010·Fundamental & Clinical Pharmacology·Justin F Deniset, Grant N Pierce
Jun 6, 2000·The Journal of Infectious Diseases·L A CampbellC Kuo
May 5, 2001·Expert Opinion on Pharmacotherapy·S E Girard, Z Temesgen
Jun 6, 2000·The Journal of Infectious Diseases·J T Grayston
Apr 20, 2002·Current Opinion in Infectious Diseases·Michael Dunne
Jul 18, 2002·Antimicrobial Agents and Chemotherapy·Ignatius W FongJames B Mahony
Apr 22, 2005·The New England Journal of Medicine·Christopher P CannonUNKNOWN Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators
Apr 21, 2006·International Journal of Experimental Pathology·Hiroyuki YamaguchiShigeru Kamiya
Feb 17, 2005·BJOG : an International Journal of Obstetrics and Gynaecology·Dimitrios G GoulisCatherine Williamson
Oct 4, 2012·Future Microbiology·Dimitrios ChatzidimitriouNikolaos Malisiovas
Jul 24, 2013·International Journal of Molecular Sciences·Marisa Di PietroRosa Sessa
Apr 7, 1999·Nature Genetics·S KalmanR S Stephens
Jun 6, 2000·The Journal of Infectious Diseases·C A Gaydos
Nov 18, 2004·Journal of Interventional Cardiology·Matthias KannengiesserJürgen Haase
Sep 30, 1998·The British Journal of Surgery·R G GibbsA H Davies

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.